Motus GI Holdings Inc
OTC:MOTS
Motus GI Holdings Inc
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 30 full-time employees. The company went IPO on 2018-02-14. The firm is engaged in developing a medical device Pure-Vu System. Pure-Vu system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Pure-Vu System facilitates the cleaning of the colon during the colonoscopy procedure. Pure-Vu System integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The firm is focused on GI bleeds clinical research . The firm's subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 30 full-time employees. The company went IPO on 2018-02-14. The firm is engaged in developing a medical device Pure-Vu System. Pure-Vu system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Pure-Vu System facilitates the cleaning of the colon during the colonoscopy procedure. Pure-Vu System integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The firm is focused on GI bleeds clinical research . The firm's subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
